Optimal extent of lymphadenectomy for gastric adenocarcinoma: A 7-institution study of the U.S. gastric cancer collaborative

Journal of Surgical Oncology

Volumn 113, Issue 7, 2016, Pages 750-755

  Randle, Reese W ^a   Swords, Douglas S ^a   Levine, Edward A ^a   Fino, Nora F ^a   Squires, Malcolm H ^b   Poultsides, George ^c   Fields, Ryan C ^d   Bloomston, Mark ^e   Weber, Sharon M ^f   Pawlik, Timothy M ^g   Jin, Linda X ^d   Spolverato, Gaya ^g   Schmidt, Carl ^e   Worhunsky, David ^c   Cho, Clifford S ^f   Maithel, Shishir K ^b   Votanopoulos, Konstantinos I ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e OHIO STATE UNIVERSITY   (United States)

^f UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

D2 lymphadenectomy; gastrectomy; gastric adenocarcinoma

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GASTRECTOMY; HEART INFARCTION; HUMAN; INFECTIOUS COMPLICATION; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STOMACH ADENOCARCINOMA; ABDOMEN; ADENOCARCINOMA; ADULT; CANCER GRADING; CLINICAL TRIAL; FACTUAL DATABASE; FOLLOW UP; METASTASIS; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; PROCEDURES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR RECURRENCE; UNITED STATES;

ABDOMEN; ADENOCARCINOMA; ADULT; AGED; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 84971298360     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.24227     Document Type: Conference Paper

References (15)

1. Torre LA, Bray F, Siegel RL, et al.,: Global cancer statistics, 2012. CA: Cancer J Clin 2015; 65: 87-108.
2. Jemal A, Center MM, DeSantis C, et al.,: Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 2010; 19: 1893-1907.
3. Siegel RL, Miller KD, Jemal A,: Cancer statistics, 2015. CA: Cancer J Clin 2015; 65: 5-29.
4. Schmidt B, Yoon SS,: D1 versus D2 lymphadenectomy for gastric cancer. J Surg Oncol 2013; 107: 259-264.
5. Hartgrink HH, van de Velde CJ, Putter H, et al.,: Extended lymph node dissection for gastric cancer: Who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 2004; 22: 2069-2077.
6. Cuschieri A, Fayers P, Fielding J, et al.,: Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: Preliminary results of the MRC randomised controlled surgical trial. The surgical cooperative group. Lancet 1996; 347: 995-999.
7. Songun I, Putter H, Kranenbarg EM, et al.,: Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 2010; 11: 439-449.
8. American Joint Committee on Cancer: Cancer Staging Manual, 7th edition. New York, NY: Springer; 2010.
9. Cuschieri A, Weeden S, Fielding J, et al.,: Patient survival after D1 and D2 resections for gastric cancer: Long-term results of the MRC randomized surgical trial. Surgical co-operative group. Br J Cancer 1999; 79: 1522-1530.
10. Sasako M, Sakuramoto S, Katai H, et al.,: Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol 2011; 29: 4387-4393.
11. Degiuli M, Sasako M, Ponti A, et al.,: Morbidity and mortality after D2 gastrectomy for gastric cancer: Results of the Italian gastric cancer study group prospective multicenter surgical study. J Clin Oncol 1998; 16: 1490-1493.
12. Degiuli M, Sasako M, Ponti A, et al.,: Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer 2004; 90: 1727-1732.
13. Spolverato G, Ejaz A, Kim Y, et al.,: Use of endoscopic ultrasound in the preoperative staging of gastric cancer: A multi-institutional study of the US gastric cancer collaborative. J Am Col Surg 2015; 220: 48-56.
14. Jin LX, Moses LE, Squires MH, III, et al.,: Factors associated with recurrence and survival in lymph node-negative gastric adenocarcinoma: A 7-institution study of the US gastric cancer collaborative. Ann Surg 2015; 262: 999-1005.
15. Smith DL, Elting LS, Learn PA, et al.,: Factors influencing the volume-outcome relationship in gastrectomies: A population-based study. Ann Surg Oncol 2007; 14: 1846-1852.